Timothy F Jones1,2, Soliana Bekele1,2, Michael J O'Dwyer1,2,3, John R Prowle1,2. 1. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. 2. Adult Critical Care Unit, Royal London Hospithal, Barts Health NHS Trust, London, United Kingdom. 3. Department of Anaesthesia, St. Vincent's University Hospital, Dublin, Ireland.
Abstract
BACKGROUND: It is increasingly recognised that improved diagnosis, prognosis and treatment of acute kidney injury (AKI) requires an understanding of distinct underling cellular and molecular mechanisms (endotypes) that may distinguish overtly similar clinical AKI presentations. One important avenue of research is the post-transcriptional regulation of gene expression in response to kidney injury mediated by microRNAs. SUMMARY: This mini-review summarises the use of microRNAs as diagnostic and prognostic biomarkers in AKI. The contribution of microRNAs to the pathophysiology of AKI will be highlighted along with the potential for therapeutic applications. Key Messages: While there is great potential for a better understanding of AKI, microRNAs form a complex regulatory network. Understanding the role and significance of microRNAs in the context of AKI and critical illness is a major endeavour in translational medicine, requiring the integration of clinical and experimental data.
BACKGROUND: It is increasingly recognised that improved diagnosis, prognosis and treatment of acute kidney injury (AKI) requires an understanding of distinct underling cellular and molecular mechanisms (endotypes) that may distinguish overtly similar clinical AKI presentations. One important avenue of research is the post-transcriptional regulation of gene expression in response to kidney injury mediated by microRNAs. SUMMARY: This mini-review summarises the use of microRNAs as diagnostic and prognostic biomarkers in AKI. The contribution of microRNAs to the pathophysiology of AKI will be highlighted along with the potential for therapeutic applications. Key Messages: While there is great potential for a better understanding of AKI, microRNAs form a complex regulatory network. Understanding the role and significance of microRNAs in the context of AKI and critical illness is a major endeavour in translational medicine, requiring the integration of clinical and experimental data.
Authors: Ioannis Bantounas; Filipa M Lopes; Kirsty M Rooney; Adrian S Woolf; Susan J Kimber Journal: Stem Cell Reports Date: 2020-12-10 Impact factor: 7.765
Authors: Adrianna Douvris; Dylan Burger; Rosendo A Rodriguez; Edward G Clark; Jose Viñas; Manoj M Lalu; Risa Shorr; Kevin D Burns Journal: Can J Kidney Health Dis Date: 2021-04-24
Authors: Evelyn M Templeton; Vicky A Cameron; John W Pickering; A Mark Richards; Anna P Pilbrow Journal: Heart Fail Rev Date: 2021-09 Impact factor: 4.214